Physician profile
Jensen Go
NPI 1225058605
$1,762.24
in general payments reported to CMS, 2019-2025
13 companies · $159 in 2025
The $159 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $127 · 2021: $237 · 2022: $115 · 2023: $386 · 2024: $363 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $500.15 | 2019-2024 | Xarelto |
| Pfizer INC. | $342.34 | 2019-2025 | |
| Abbott Laboratories | $205.46 | 2019-2025 | Amplatzer Talisman, Thoratec Heartmate 3 Lvas Implant Kit |
| Glaxosmithkline, LLC. | $175.18 | 2020-2023 | Nucala, Trelegy Ellipta |
| E.R. Squibb & Sons, L.L.C. | $121.98 | 2019-2025 | Camzyos |
| Merck Sharp & Dohme LLC | $99.60 | 2022-2024 | Dificid, Zerbaxa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.98 | 2024-2025 | Lifevest |
| Abbvie INC. | $67.78 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.96 | 2024 | Jardiance |
| Gilead Sciences, INC. | $47.59 | 2024 | |
| Atricure, INC. | $28.35 | 2024 | |
| Boston Scientific Corporation | $26.67 | 2025 | General - Therapies |
| Edwards Lifesciences Corporation | $25.20 | 2024 | Sapien 3 Ultra Resilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jensen Go listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.